Showing results (161-170 of 182) with videos related to
Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2023
Collaborative privacy-preserving analysis of oncological data using multiparty homomorphic encryptionRavit Geva, Alexander Gusev, Yuriy Polyakov, et al.Neuro-Oncology|December 18, 2019
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II studyAndrew J Brenner, Katherine B Peters, James Vredenburgh, et al.Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.Neuro-Oncology|April 29, 2017
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825Haley Gittleman, Daniel Lim, Michael W Kattan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trialMark R Gilbert, Meihua Wang, Kenneth D Aldape, et al.Neuro-Oncology|December 3, 2014
Delayed contrast extravasation MRI: a new paradigm in neuro-oncologyLeor Zach, David Guez, David Last, et al.Journal for Immunotherapy of Cancer|June 6, 2025
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccinationHenning Zelba, Borong Shao, Armin Rabsteyn, et al.JAMA Oncology|January 19, 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525Erica Hlavin Bell, Stephanie L Pugh, Joseph P McElroy, et al.Neuro-Oncology|April 4, 2017
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOGDeborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, et al.The New England Journal of Medicine|February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastomaMark R Gilbert, James J Dignam, Terri S Armstrong, et al.Pageof 19